Reports
Reports
Sale
The global population health management market size attained a value of USD 42.53 billion in 2023. The market is anticipated to grow at a CAGR of 17% during the forecast period of 2024-2032 to attain a value of USD 174.73 billion by 2032. The market growth is driven by the increased innovation in analytical devices and widespread application across the globe.
Population health management (PHM) is a systematic, all-encompassing approach to gather and analyse patient-specific health data. It includes patient involvement, data analytics, care coordination, integration, measurement of value-based healthcare, and health information management. It emphasises enhancing patient results, overall patient experience, and population health.
The population health management market demand is anticipated to witness further growth due to the increasing use of IT in the healthcare industry. The market growth is expected to be driven by advantages provided by population health management systems, such as data integration, remote patient monitoring, and data storage. Also, the use of IT solutions, particularly in business intelligence and data analytics, is also supporting the growth of the market.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Value-based payment (VBP) models have replaced fee-for-service (FFS) models as a result of the growing demand from healthcare stakeholders for solutions supporting value-based care delivery. The market is also anticipated to increase as a result of the rising demand for efficient disease management techniques.
The growing emphasis on personalised medicines will present advantageous chances for population health management to advance. Businesses in the healthcare industry can treat each patient uniquely using cutting-edge analytics and predictive modeling technologies, producing the best possible results and contributing significantly to the population health management market share.
Increased healthcare investments in the market have also been contributing significantly to the market growth, resulting in the growing deployment of healthcare information technology. Additionally, rising urbanisation and increased spending on healthcare infrastructure are also likely to escalate the demand for population health management.
Strategic Collaborations between Key Players to Bring the Best Solution in the Market
Rising collaborations between the leading companies in the market are anticipated to provide significant impetus to population health management market growth. In October, 2023, Wolters Kluwer Health announced its Health Language Platform, an FHIR Terminology Server, that will work with Microsoft Azure Health Data Services FHIR service to help customers enrich and standardize their healthcare data with medical ontologies on Microsoft Azure. Wolters Kluwer Health organizes health data to make it insightful and comprehendible and Microsoft Azure will provide safety and security to the data making it better and accessible to healthcare professionals and enhancing the decision-making process and overall population health management. This collaboration is expected to drive traction of healthcare market players towards such solutions and potential future investments to continuously improve the existing solution, resulting in increased global population health management market demand and projecting an upward trajectory during the forecast period.
Rising Introduction of Innovative Products to Drive Significant Growth
In September 2023, ClosedLoop, a healthcare data science platform, launched two new solutions, ACO-Predict and Evaluate, to help measure and guide the real-world impact of healthcare programs. The tools are designed to help healthcare organizations analyze, evaluate, monitor, and refine their programs to mitigate adverse events, improve outcomes, and reduce unnecessary costs. Such tools are perfect for healthcare organizations trying to assess whether their healthcare programs are performing well or not. When healthcare programs can exhibit positive results, such as improving health outcomes, avoiding problems, and saving money, they are likely to be adopted by more organizations, propelling market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Components
Market Breakup by Mode of Delivery
Market Breakup by End User
Market Breakup by Distribution Channel
Market Breakup by Region
North America is expected to lead the global market for population health management owing to the rise in healthcare expenses and increasing geriatric population. By precisely measuring the health of the population and its subgroups, governments are putting more effort into providing incentives and implementing programs to enhance the state of the health of their respective countries. The market for population health management in North America is further anticipated to be driven by factors such as increasing diseases, regulatory environment, pressure on the healthcare industry to lower medical expenses, expanding use of information technology in healthcare, and cloud computing.
For instance, in October 2023, The Department of Health and Mental Hygiene launched a new Center for Population Health Data Science. The Center will speed up critical internal work and enable the agency, in its role as the City’s health strategist, to make progress toward linking public health, healthcare, and social service data. The new center targets to assist New York City’s population health surveillance, and improve outcomes by linking healthcare, public health, and social service data, bolstering the population health management market growth. The accumulated data at the new center will enable healthcare professionals to keep track of patterns and comprehend the requirements of healthcare in specific neighborhoods. Such efforts help the health department and other organizations plan and create better ways to take care of everyone's health.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
In September 2023, Health Catalyst, Inc., a company that offers data and analytics technology and services to healthcare organizations has recently announced that two of its technologies, Health Catalyst Pop Analyzer™ and Health Catalyst Care Flow™, have received National Committee for Quality Assurance (NCQA) Prevalidation for Population Health Management in 2023.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Components |
|
Breakup by Mode of Delivery |
|
Breakup by End User |
|
Breakup by Distribution Channels |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Population Health Management Market Overview
3.1 Global Population Health Management Market Historical Value (2017-2024)
3.2 Global Population Health Management Market Forecast Value (2024-2032)
4 Global Population Health Management Market Landscape
4.1 Global Population Health Management Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Population Health Management Product Landscape
4.2.1 Analysis by Components
4.2.2 Analysis by Mode of Delivery
5 Global Population Health Management Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Population Health Management Market Segmentation
6.1 Global Population Health Management Market by Components
6.1.1 Market Overview
6.1.2 Software
6.1.3 Services
6.1.3.1 Post-Sale and Maintenance Services
6.1.3.2 Consulting Services
6.1.3.3 Training and Education Service
6.1.3.4 Implementation Services
6.2 Global Population Health Management Market by Mode of Delivery
6.2.1 Market Overview
6.2.2 On-Premises
6.2.3 Cloud Based
6.3 Global Population Health Management Market by End User
6.3.1 Market Overview
6.3.2 Healthcare Providers
6.3.3 Healthcare Payers
6.3.4 Employer Group
6.3.5 Government Bodies
6.3.6 Others
6.4 Global Population Health Management Market by Distribution Channel
6.4.1 Market Overview
6.4.2 Hospitals Pharmacies
6.4.3 Retail Pharmacies
6.4.4 Online Pharmacies
6.4.5 Others
6.5 Global Population Health Management Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Population Health Management Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Population Health Management Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Population Health Management Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Population Health Management Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Population Health Management Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 MCKESSON CORPORATION
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Verisk Analytics, Inc
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Forward Health Group, Inc
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Health Catalyst
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Athenahealth, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Cerner Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Medecision
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Xerox Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Allscripts Healthcare, LLC
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Fonemed
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 General Electric
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 HealthBI
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 NXGN Management, LLC
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Optum Inc.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Conifer Health Solutions, LLC
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Siemens Healthcare GmbH
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 IBM
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
17.18 Koninklijke Philips N.V.
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisitions
17.18.5 Certifications
18 Global Population Health Management Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 42.53 billion in 2023, driven by increasing focus on patient population.
The market is anticipated to grow at a CAGR of 17% during the forecast period of 2024-2032, likely to reach a market value of USD 174.73 billion by 2032.
The increasing adaptation of advanced technologies in healthcare, remote patient monitoring, enhanced data storage, increased healthcare investments, growing emphasis on personalised medicines, and increased product launches are the major factors driving the market growth.
The increased strategic collaborations between key players like Wolters Kluwer Health announcing its Health Language Platform, an FHIR Terminology Server that will work with Microsoft Azure Health Data Services FHIR service are a major trend influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Components in the market include software and services. Services are further categorised into post-sale and maintenance services, consulting services, training and education services, and implementation services.
Modes of delivery include on-premises and cloud-based delivery.
End users in the market include healthcare providers, healthcare payers, employer groups, and government bodies, among others.
Distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies, among others.
Key players involved in the market are MCKESSON CORPORATION, Verisk Analytics, Inc, Forward Health Group, Inc, Health Catalyst, Athenahealth, Inc., Cerner Corporation, Medecision, Xerox Corporation, Allscripts Healthcare, LLC, Fonemed, General Electric, HealthBI, NXGN Management, LLC, Optum Inc., Conifer Health Solutions, LLC, Siemens Healthcare GmbH, Koninklijke Philips N.V., and IBM.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.